BEAM
Beam Therapeutics Inc Earnings
$21.16
Earnings Summary
Revenue | $7.47Mn |
Net Profits | $-109.27Mn |
Net Profit Margins | -1462.78% |
Beam Therapeutics Inc’s revenue jumped 0.81% since last year same period to $7.47Mn in the Q1 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated -75.16% fall in its revenue since last 3-months.
Beam Therapeutics Inc’s net profit fell -10.74% since last year same period to $-109.27Mn in the Q1 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated -20.94% fall in its net profits since last 3-months.
Beam Therapeutics Inc’s net profit margin fell -9.85% since last year same period to -1462.78% in the Q1 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated -386.77% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.11 |
EPS Estimate Current Year | -1.11 |
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.11 - a 5.24% jump from last quarter’s estimates.
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.11.
Key Ratios
Earning Per Share (EPS) | 0 |
Beam Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Beam Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-06 | -1.17 | -1.24 | -6.04% |
2025-08-12 | -1.11 | 0 | 100% |
